Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower ...
A group of drug wholesalers, retailers, health plans and others have asked a U.S. appeals court to revive their lawsuits accusing pharmaceutical company Ranbaxy of conspiring with Pfizer to delay the ...
Case A describes its market entry and rise to market leadership. Positioned as a more effective product, Lipitor was the fifth entrant into a well-established category with strongly entrenched ...